Skip Navigation
Visitor Restrictions Update: Because flu & RSV cases are on the rise, starting November 16, children 12 and younger are restricted from visiting hospitals, certain inpatient facilities, and all emergency departments. Learn more.

Advancing Care for Patients with Liver Disease

Providing the highest level of care through a multidisciplinary approach, our dedicated team conducts research to improve health and advance care for patients with chronic liver disease or liver transplantation.

With a focus on Phase II - III clinical trials, our team of hepatologists, clinical research nurses and coordinators, pharmacists, surgeons and other specialists works together to integrate innovative translational research with evidence-based clinical research, giving patients access to optimal care and therapies.

Our current areas of research include:

  • Autoimmune hepatitis
  • Cirrhosis
  • Hepatocellular carcinoma
  • Liver transplantation
  • Nonalcoholic liver fatty disease (NAFLD)
  • Primary biliary cirrhosis
  • Primary sclerosing cholangitis
  • Value-based care in liver disease
  • Viral hepatitis

Our research team has contributed to:

  • The cure for Hepatitis C
  • Therapy of nonalcoholic fatty liver disease
  • Novel, innovative therapy for primary biliary cholangitis and primary sclerosing cholangitis
  • Developing biomarkers for liver fibrosis
  • Successfully reducing 30- and 90-day readmissions by 50 percent after liver transplant